266 related articles for article (PubMed ID: 28602843)
1. Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse model.
Kadkhodayan S; Jafarzade BS; Sadat SM; Motevalli F; Agi E; Bolhassani A
Immunol Lett; 2017 Aug; 188():38-45. PubMed ID: 28602843
[TBL] [Abstract][Full Text] [Related]
2. Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity.
Milani A; Bolhassani A; Shahbazi S; Motevalli F; Sadat SM; Soleymani S
Immunol Lett; 2017 Nov; 191():16-22. PubMed ID: 28917624
[TBL] [Abstract][Full Text] [Related]
3. Improving the potency of DNA vaccine encoding HIV-1 Nef antigen using two endogenous adjuvants in mouse model.
Jafarzade BS; Sadat SM; Yaghobi R; Bolhassani A
Bratisl Lek Listy; 2017; 118(9):564-569. PubMed ID: 29061065
[TBL] [Abstract][Full Text] [Related]
4. In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate.
Davoodi S; Bolhassani A; Namazi F
Biotechnol Lett; 2021 Mar; 43(3):547-559. PubMed ID: 33386500
[TBL] [Abstract][Full Text] [Related]
5. Gene and protein delivery using four cell penetrating peptides for HIV-1 vaccine development.
Rostami B; Irani S; Bolhassani A; Cohan RA
IUBMB Life; 2019 Oct; 71(10):1619-1633. PubMed ID: 31220406
[TBL] [Abstract][Full Text] [Related]
6. Heterologous DNA Prime/Protein Boost Immunization Targeting Nef-Tat Fusion Antigen Induces Potent T-cell Activity and in vitro Anti-SCR HIV-1 Effects.
Sadeghi L; Bolhassani A; Mohit E; Baesi K; Aghasadeghi MR
Curr HIV Res; 2024 May; ():. PubMed ID: 38712371
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Efficacy of HIV-1 Nef-Tat-Gp160-p24 Polyepitope Vaccine Candidate with Nef Protein in Different Immunization Strategies.
Namazi F; Davoodi S; Bolhassani A
Curr Drug Deliv; 2022; 19(1):142-156. PubMed ID: 33655833
[TBL] [Abstract][Full Text] [Related]
8. LL-37 antimicrobial peptide and heterologous prime-boost vaccination regimen significantly induce HIV-1 Nef-Vpr antigen- and virion-specific immune responses in mice.
Nikyar A; Bolhassani A; Agi E
Biotechnol Lett; 2023 Jan; 45(1):33-45. PubMed ID: 36550339
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of two HIV-1 multiepitope polypeptides for stimulation of immune responses in BALB/c mice.
Kardani K; Hashemi A; Bolhassani A
Mol Immunol; 2020 Mar; 119():106-122. PubMed ID: 32007753
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous use of natural adjuvants and cell penetrating peptides improves HCV NS3 antigen-specific immune responses.
Alizadeh S; Irani S; Bolhassani A; Sadat SM
Immunol Lett; 2019 Aug; 212():70-80. PubMed ID: 31254535
[TBL] [Abstract][Full Text] [Related]
11. The Efficiency of Tat Cell Penetrating Peptide for Intracellular Uptake of HIV-1 Nef Expressed in E. coli and Mammalian Cell.
Kadkhodayan S; Bolhassani A; Sadat SM; Irani S; Fotouhi F
Curr Drug Deliv; 2017; 14(4):536-542. PubMed ID: 27719633
[TBL] [Abstract][Full Text] [Related]
12. Comparison of six cell penetrating peptides with different properties for in vitro and in vivo delivery of HPV16 E7 antigen in therapeutic vaccines.
Shahbazi S; Bolhassani A
Int Immunopharmacol; 2018 Sep; 62():170-180. PubMed ID: 30015237
[TBL] [Abstract][Full Text] [Related]
13. Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responses.
Bolhassani A; Kardani K; Vahabpour R; Habibzadeh N; Aghasadeghi MR; Sadat SM; Agi E
Immunol Lett; 2015 Dec; 168(2):366-73. PubMed ID: 26518142
[TBL] [Abstract][Full Text] [Related]
14. Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses.
Velashjerdi Farahani S; Reza Aghasadeghi M; Memarnejadian A; Faezi S; Shahosseini Z; Mahdavi M
Pathog Glob Health; 2016 Mar; 110(2):39-47. PubMed ID: 26403975
[TBL] [Abstract][Full Text] [Related]
15. Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice.
Moore AC; Kong WP; Chakrabarti BK; Nabel GJ
J Virol; 2002 Jan; 76(1):243-50. PubMed ID: 11739689
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Adjuvant Effects of Montanide ISA-720 and Heat Shock Protein 27 in Increasing Immunostimulatory Properties of HIV-1 Nef-Vif Fusion Protein Construct.
Khairkhah N; Shahhosseini F; Agi E; Milani A; Bolhassani A
Protein Pept Lett; 2023; 30(5):401-410. PubMed ID: 37016523
[TBL] [Abstract][Full Text] [Related]
17. ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses.
Mahdavi M; Ebtekar M; Khorram Khorshid HR; Azadmanesh K; Hartoonian C; Hassan ZM
Immunol Lett; 2011 Oct; 140(1-2):14-20. PubMed ID: 21679728
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
[TBL] [Abstract][Full Text] [Related]
19. Engineered dendritic cells-derived exosomes harboring HIV-1 Nef
Pordanjani PM; Bolhassani A; Pouriayevali MH; Milani A; Rezaei F
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132236. PubMed ID: 38768924
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost.
Billaut-Mulot O; Idziorek T; Loyens M; Capron A; Bahr GM
Vaccine; 2001 Apr; 19(20-22):2803-11. PubMed ID: 11282190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
